“CannPal was founded by a team of experienced medicinal cannabis and veterinary executives to produce animal therapeutics for emerging global pet pharmaceutical markets.”

Real Problems

Animals deserve the same compassion to help ease their suffering that humans do. Having an animal companion is one of the greatest joys in life, and supporting them through illness and the end of life can be one of the most difficult times.


Real Experts

Using global strategic partners, we are fast tracking R&D by leveraging the medical cannabis research in humans and adapting it to animal health. Our management team is world class and our advisers have the skills required to drive our company growth.


Real Solutions

59% of the drugs prescribed by Veterinarians are off label human medicines that are often accompanied by internal bleeding, nausea, diarrhoea and in some cases, death. We’re developing therapeutics that offer both relief and safety for your pets.



The animal population is ageing and age related disease is growing at a quicker rate than new product innovation and development.

It’s estimated that over 60% of dogs between the ages of 7 and 11 years will experience arthritis, 1 in 2 will get some form of cancer and 1 in 4 dogs will die from the disease. 61% of felines over the age of 6 have Arthritis in at least 1 joint and 30% will be affected by a tumour at some point in their lives.

The medication available to pets for these indications can provide negative side effects including nausea, loss of appetite, depression and internal bleeding. Pets are also becoming increasingly resistant to non-steroidal anti-inflammatory drugs and other pharmaceutical therapies.

CannPal is working to further explore the natural healing abilities of cannabinoids, to develop novel and efficacious therapies for your companions, without the associated negative side effects, to enhance their quality of life.

GroundbreakingPain Management

Developing a number of pain management drugs, focusing on inflammation, arthritis and post-surgery pain.

Drastically improvedBehaviour issues

With a focus on behaviour modifying agents for use in problem dogs, including separation anxiety & aggression.

Reduced and remediedSkin disease

Innovative topical lotions and applications to treat Atopic Dermatitis and other skin disease, including itchiness.

Leading the packWhat makes us different


We’ve aligned ourselves with some of the worlds leading veterinary research organisations across the globe.

Global reach

Our strategic partners include global market leading cannabis cultivators and oil suppliers.

Clinical Development

We’re committed to providing veterinarians with safe and efficacious, regulatory approved medicines.

Expert team

Our advisers are industry thought leaders with experience in commercial veterinary drug development and research 

Innovative Pipeline

We have an innovative pipeline targeting specific unmet needs in the pet pharmaceutical market.

Long-term Strategy

A diversified portfolio to expose CannPal to long term and short term revenues through OTC and regulatory therapies.

Want more information ? Get in touch with us here.

Latest News